Duane C, Glavey S, Quinn J, Murphy P. Significant risk of venous thromboembolism associated with targeted anti-myeloma immunomodulatory drugs. Comment on “Targeted anti-cancer agents and risk of venous thromboembolism”. Haematologica 2025;110(10):2552-2553; https://doi.org/10.3324/haematol.2025.287442.